APA (7th ed.) Citation

MS, A., EM, M., A, H., AN, R., H, O., AA, Z., . . . EI, E. (2023). Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial. CNS neuroscience & therapeutics, 29(1), 354. https://doi.org/10.1111/cns.14010

Chicago Style (17th ed.) Citation

MS, Abdallah, Mosalam EM, Hassan A, Ramadan AN, Omara-Reda H, Zidan AA, Samman WA, and El-Berri EI. "Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia: A Double-blind, Randomized, Placebo-controlled Trial." CNS Neuroscience & Therapeutics 29, no. 1 (2023): 354. https://doi.org/10.1111/cns.14010.

MLA (9th ed.) Citation

MS, Abdallah, et al. "Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia: A Double-blind, Randomized, Placebo-controlled Trial." CNS Neuroscience & Therapeutics, vol. 29, no. 1, 2023, p. 354, https://doi.org/10.1111/cns.14010.